This report analyzes vitamin D status in older Irish adults using data from The Irish Longitudinal Study on Ageing (TILDA). It finds:
1) During winter, 21.3% of adults over 55 were vitamin D deficient, with rates increasing with age (46.6% of those over 85 deficient).
2) Deficiency rates were high across all regions of Ireland, with those over 85 in Connacht & Ulster having the highest rate (59.5% deficient).
3) Only 9.4% of those over 55 and 11.5% of those over 70 reported taking a vitamin D supplement in winter. Supplement use was much higher in women than men.
Vitamin D and COVID-19
Presentation at the Ancestral Health Symposium (AHS) 2021
by Chris Masterjohn, PhD
Watch the presentation recording, download a PDF version of the slides, and read the written report at https://chrismasterjohnphd.com/vitamind
Current State of Evidence: Vitamin D and Immunity During the COVID-19 PandemicUN SPHS
By Dr. Maha Alturki, Associate Dean of Academic Affairs, College of Applied Medical Sciences, King Saud bin Abdul-Aziz University for Health Science (KSAU-HS) delivered at the Global Forum 2020 Food Safety and Risk Assessment session.
Are Vitamin D Levels Associated with COVID 19 Prevalence and Outcomesijtsrd
Since December 2019, coronavirus infection disease 2019 COVID 19 due to a new coronavirus, severe acute respiratory syndrome type 2 SARS CoV2 infection, occurred mainly in Wuhan City, Hubei Province, China, and spread worldwide throughout a short period of time. The COVID 19 pandemic is shaking the world. To date, the route of infection, treatment methods, and the process since infection have not been clarified. Therefore, various researches and studies are being carried out at a rapid pace in research institutions around the world to clarify the novel coronavirus. Vitamin D helps to balance calcium and helps maintain bone health. Vitamin D is considered to be physiologically effective for enhancing immunity, cancer, diabetes, autism, and making the body easy to conceive. Recent studies have reported an association between the amount of vitamin D in the body and the severity of COVID 19. In this review, we provide a compact, comprehensive description of the relationship between vitamin D and COVID 19. Takuma Hayashi | Ikuo Konishi "Are Vitamin D Levels Associated with COVID-19 Prevalence and Outcomes?" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd31433.pdf Paper Url :https://www.ijtsrd.com/medicine/other/31433/are-vitamin-d-levels-associated-with-covid19-prevalence-and-outcomes/takuma-hayashi
Vitamin D Part 1- Covid19 and Vitamin DHANISH BABU
Covid19 and Vitamin D is part 1 of 3 of the Webinar series on Vitamin D in Health and Disease by Dr Hanish Babu. 2 Major Text Books, more than 250 Journal references and reference from dozens of Videos on Vitamin D from experts world over and 4 months of intensive research has gone into the preparation of these talks.
As a service to the public health, these presentations are free to use for educational purposes, with proper acknowledgements.
Dr Hanish Babu, MD, 2020
Vitamin D and COVID-19
Presentation at the Ancestral Health Symposium (AHS) 2021
by Chris Masterjohn, PhD
Watch the presentation recording, download a PDF version of the slides, and read the written report at https://chrismasterjohnphd.com/vitamind
Current State of Evidence: Vitamin D and Immunity During the COVID-19 PandemicUN SPHS
By Dr. Maha Alturki, Associate Dean of Academic Affairs, College of Applied Medical Sciences, King Saud bin Abdul-Aziz University for Health Science (KSAU-HS) delivered at the Global Forum 2020 Food Safety and Risk Assessment session.
Are Vitamin D Levels Associated with COVID 19 Prevalence and Outcomesijtsrd
Since December 2019, coronavirus infection disease 2019 COVID 19 due to a new coronavirus, severe acute respiratory syndrome type 2 SARS CoV2 infection, occurred mainly in Wuhan City, Hubei Province, China, and spread worldwide throughout a short period of time. The COVID 19 pandemic is shaking the world. To date, the route of infection, treatment methods, and the process since infection have not been clarified. Therefore, various researches and studies are being carried out at a rapid pace in research institutions around the world to clarify the novel coronavirus. Vitamin D helps to balance calcium and helps maintain bone health. Vitamin D is considered to be physiologically effective for enhancing immunity, cancer, diabetes, autism, and making the body easy to conceive. Recent studies have reported an association between the amount of vitamin D in the body and the severity of COVID 19. In this review, we provide a compact, comprehensive description of the relationship between vitamin D and COVID 19. Takuma Hayashi | Ikuo Konishi "Are Vitamin D Levels Associated with COVID-19 Prevalence and Outcomes?" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd31433.pdf Paper Url :https://www.ijtsrd.com/medicine/other/31433/are-vitamin-d-levels-associated-with-covid19-prevalence-and-outcomes/takuma-hayashi
Vitamin D Part 1- Covid19 and Vitamin DHANISH BABU
Covid19 and Vitamin D is part 1 of 3 of the Webinar series on Vitamin D in Health and Disease by Dr Hanish Babu. 2 Major Text Books, more than 250 Journal references and reference from dozens of Videos on Vitamin D from experts world over and 4 months of intensive research has gone into the preparation of these talks.
As a service to the public health, these presentations are free to use for educational purposes, with proper acknowledgements.
Dr Hanish Babu, MD, 2020
Γρηγόριος Γεροτζιάφας, Health Innovation Conference 2021Starttech Ventures
Ομιλία – Παρουσίαση:“Artificial intelligence and personalised medicine for patients at high risk of severe COVID-19”
Γρηγόριος Γεροτζιάφας, Καθηγητής Αιματολογίας, Ιατρική σχολή της Σορβόνης, Υπεύθυνος, Τμήμα Θρόμβωσης, Νοσοκομείο Tenon, Παρίσι & Διευθυντής, Ερευνητική Ομάδα Καρκίνος και Θρόμβωση INSERM U938
Medium com-@franramazon-vitamin-d-can-help-reduce-coronavirus-risk-by-54-boston-FranciscoGarca866573
80% of C*V*D-19 Deaths Have THIS On Their Body
Shocking reports from around the world are revealing one surprising statistic…
Coronavirus
Coronavirus Update
Coronavirus Covid19
Covid 19
Covid Weight Gain
Covid19 Immunoboosters : Role of Vitamin C Zinc and Vitamin DShivani Sachdev
Diet and nutrition invariably influence the immune system competence and determine the risk and severity of infections.
There are bi-directional relationships among diet, nutrition, infection, and immunity. The changes in one component have an impact on the others. Vitamin C may help shorten the duration and severity of colds caused by other viruses, but this is no guarantee that it will have the same effect on the coronavirus that causes COVID-19.
Nevertheless it is safe and inexpensive
The Upper Limit (UL) for supplemental vitamin C — the amount most people can consume daily without negative effects — is 2,000 mg .
Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020 Apr William B Grant. Lower viral replication rates
Reduce concentrations of pro-inflammatory cytokines that produce the inflammation that injures the lining of the lungs, leading to pneumonia. Increase concentrations of anti-inflammatory cytokines . Evidence supporting the role of vitamin D in reducing risk of COVID-19. Outbreak occurred in winter, a time when 25(OH)D3 concentrations are lowest
The number of cases in the Southern Hemisphere are low
Vitamin D deficiency has been found to contribute to acute respiratory distress syndrome
Case-fatality rates increase with age with chronic disease comorbidity, and also higher in dark skinned people and all of which are associated with lower 25(OH)D concentration
Vitamin-D and COVID-19: do deficient risk a poorer outcome? Fiona Mitchell Lancet 2020.
How Nutrition Can Help Fight Against the COVID-19 PandemicUN SPHS
By Dr. Randah Miqbil Alqurashi Assistant Professor, King Faisal University, delivered at the Global Forum 2020 Food Safety and Risk Assessment session.
A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19ijtsrd
Coronavirus disease COVID 19 is an infectious disease caused by the SARS CoV 2 coronavirus, which has spread rapidly across the world. The World Health Organization WHO proclaimed the COVID 19 outbreak a pandemic in March 2020. The pandemic has wreaked havoc on global health systems, as well as economic and social development. The rate of transmission is relatively high.As a result, regardless of vaccine history or previous infection, the CDC recommends that anyone with any signs or symptoms of COVID 19 be checked. Everyday Preventive Actions, as well as having the Covid 19 Vaccine when it is safe, will protect you and your loved ones. Prof. Dr. Anup Kumar Das | Dr. Humani Sharma | Dr. Hitarth Mehta "A Perspective Approach of Community Medicine in Corona Virus Disease (COVID 19)" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd43677.pdf Paper URL: https://www.ijtsrd.comother-scientific-research-area/other/43677/a-perspective-approach-of-community-medicine-in-corona-virus-disease-covid-19/prof-dr-anup-kumar-das
The Coronavirus (COVID-19) Outbreak and Data-driven Healthcare: A Biomedical ...Jake Chen
The ongoing outbreak of coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has led to more than 80,000 confirmed cases and nearly 3000 deaths worldwide since December 2019. There is a race in the biomedical research community to publish findings on a wide spectrum of topics, from pathogenicity, viral genome characterization, genetic epidemiology, disease management, treatment, to drug and vaccine development. I will review literature primarily from the epidemiology, genomics, computational biology, and translational bioinformatics perspectives to help us understand the basic biomedical research questions related to the COVID-19 outbreak. These questions include: what is a coronavirus, how the viral genome is organized, how it compares with SARS, what biochemical and genomic characteristics that it has to make it so virulent, and what genomics/informatics/drug discovery opportunities there are. The rapid data collection, analysis, publication, healthcare intervention, and drug development presents a promising new model for “data-driven healthcare” in response to future major disease outbreak events.
Γρηγόριος Γεροτζιάφας, Health Innovation Conference 2021Starttech Ventures
Ομιλία – Παρουσίαση:“Artificial intelligence and personalised medicine for patients at high risk of severe COVID-19”
Γρηγόριος Γεροτζιάφας, Καθηγητής Αιματολογίας, Ιατρική σχολή της Σορβόνης, Υπεύθυνος, Τμήμα Θρόμβωσης, Νοσοκομείο Tenon, Παρίσι & Διευθυντής, Ερευνητική Ομάδα Καρκίνος και Θρόμβωση INSERM U938
Medium com-@franramazon-vitamin-d-can-help-reduce-coronavirus-risk-by-54-boston-FranciscoGarca866573
80% of C*V*D-19 Deaths Have THIS On Their Body
Shocking reports from around the world are revealing one surprising statistic…
Coronavirus
Coronavirus Update
Coronavirus Covid19
Covid 19
Covid Weight Gain
Covid19 Immunoboosters : Role of Vitamin C Zinc and Vitamin DShivani Sachdev
Diet and nutrition invariably influence the immune system competence and determine the risk and severity of infections.
There are bi-directional relationships among diet, nutrition, infection, and immunity. The changes in one component have an impact on the others. Vitamin C may help shorten the duration and severity of colds caused by other viruses, but this is no guarantee that it will have the same effect on the coronavirus that causes COVID-19.
Nevertheless it is safe and inexpensive
The Upper Limit (UL) for supplemental vitamin C — the amount most people can consume daily without negative effects — is 2,000 mg .
Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020 Apr William B Grant. Lower viral replication rates
Reduce concentrations of pro-inflammatory cytokines that produce the inflammation that injures the lining of the lungs, leading to pneumonia. Increase concentrations of anti-inflammatory cytokines . Evidence supporting the role of vitamin D in reducing risk of COVID-19. Outbreak occurred in winter, a time when 25(OH)D3 concentrations are lowest
The number of cases in the Southern Hemisphere are low
Vitamin D deficiency has been found to contribute to acute respiratory distress syndrome
Case-fatality rates increase with age with chronic disease comorbidity, and also higher in dark skinned people and all of which are associated with lower 25(OH)D concentration
Vitamin-D and COVID-19: do deficient risk a poorer outcome? Fiona Mitchell Lancet 2020.
How Nutrition Can Help Fight Against the COVID-19 PandemicUN SPHS
By Dr. Randah Miqbil Alqurashi Assistant Professor, King Faisal University, delivered at the Global Forum 2020 Food Safety and Risk Assessment session.
A Perspective Approach of Community Medicine in Corona Virus Disease COVID 19ijtsrd
Coronavirus disease COVID 19 is an infectious disease caused by the SARS CoV 2 coronavirus, which has spread rapidly across the world. The World Health Organization WHO proclaimed the COVID 19 outbreak a pandemic in March 2020. The pandemic has wreaked havoc on global health systems, as well as economic and social development. The rate of transmission is relatively high.As a result, regardless of vaccine history or previous infection, the CDC recommends that anyone with any signs or symptoms of COVID 19 be checked. Everyday Preventive Actions, as well as having the Covid 19 Vaccine when it is safe, will protect you and your loved ones. Prof. Dr. Anup Kumar Das | Dr. Humani Sharma | Dr. Hitarth Mehta "A Perspective Approach of Community Medicine in Corona Virus Disease (COVID 19)" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd43677.pdf Paper URL: https://www.ijtsrd.comother-scientific-research-area/other/43677/a-perspective-approach-of-community-medicine-in-corona-virus-disease-covid-19/prof-dr-anup-kumar-das
The Coronavirus (COVID-19) Outbreak and Data-driven Healthcare: A Biomedical ...Jake Chen
The ongoing outbreak of coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has led to more than 80,000 confirmed cases and nearly 3000 deaths worldwide since December 2019. There is a race in the biomedical research community to publish findings on a wide spectrum of topics, from pathogenicity, viral genome characterization, genetic epidemiology, disease management, treatment, to drug and vaccine development. I will review literature primarily from the epidemiology, genomics, computational biology, and translational bioinformatics perspectives to help us understand the basic biomedical research questions related to the COVID-19 outbreak. These questions include: what is a coronavirus, how the viral genome is organized, how it compares with SARS, what biochemical and genomic characteristics that it has to make it so virulent, and what genomics/informatics/drug discovery opportunities there are. The rapid data collection, analysis, publication, healthcare intervention, and drug development presents a promising new model for “data-driven healthcare” in response to future major disease outbreak events.
Vitamin D Deficiency: Useful Causes, Consequences, and Management 2023 | The ...The Lifesciences Magazine
Vitamin D insufficiency is often underdiagnosed or untreated among the worldwide population, even though vitamin D supplementation is safe and relatively affordable. Beginning at about six months of age, children with vitamin D deficiency show signs of skeletal abnormalities. While bending at the knees is the most noticeable sign, knock knees (genu valgum) may also occur.
“It’s cheaper to clean up a mess than to avoid a mess.” This mantra, coined by Alan Greenspan explaining why financial bubbles happen, stands very much at the core of how we as a society typically seem to deal with health: rather than nudging and rewarding people to conduct a healthier life and increase their immunity, the primary focus of efforts and resources is often on treating sickness.
How can this change? What role do health data, nutrition and immunity play in this? And what difference would it make? Find out at our next DayOne Experts Event, co-hosted by DSM Nutritional Products.
There are a couple of reasons why it is not an easy thing to successfully implement preventive measures. First of all, behavioral change is hard to accomplish. Secondly, in most cases it is challenging to show the scientific evidence that a certain measure works and is worth the effort. One key focus area is the importance of an optimal nutrient intake to support our health – with a focus on immunity and beyond. Last but not least, we need to consider a business and policy model that makes prevention less of a moral burden but a worthwhile experience that we are willing to apply in a smart way.
These are the big questions we will address at the DayOne Experts Event:
Will the rise of digital and data availability change the landscape – and if so to what extent?
What can we learn from the current pandemic?
Does nutrition play a role in supporting your immunity?
Which data should we take into consideration to shape the future?
This was our conversation. Read the conclusions here: https://www.dayone.swiss/as-shown-by-covid-19-making-prevention-smart-requires-a-mind-shift/
Our partner: DSM Nutritional Products
Adult Vaccination in an ageing society: Immune responseILC- UK
Highlights the importance of vaccinating older people in the context of an ageing society. Sets out how levels of uptake vary across Europe. And highlights ideas for policy makers on how to increase uptake of adult vaccination
David Sinclair on the challenges of vaccinating adultsILC- UK
Presented at the IFA Champions Summit in early November, Director of the International Longevity Centre - UK, David Sinclair, considers the challenges and solutions to vaccinating adults.
https://www.biomedscidirect.com/2829/an-overview-of-coronavirus-disease-covid-19?utm=articles
An overview of coronavirus disease (covid-19)
Authors:Emy Jancy Rani J.
Int J Biol Med Res. 2023; 14(4): 7687-7691 | Abstract | PDF File
Vitamin D, often referred to as the "sunshine vitamin," is a remarkable nutrient that holds a multitude of secrets. Beyond its well-known role in supporting bone health, vitamin D has been the subject of extensive scientific research, uncovering its profound impact on various aspects of human health. From its influence on the immune system and mental well-being to its potential in preventing chronic diseases, vitamin D continues to captivate researchers and health enthusiasts alike.
Covid 19 Scope of Ayurveda and Homoeopathy to Make Swastha Bharatijtsrd
AYUSH system is based on traditional health practices. The traditional Healthcare system of the country provides lifestyle advocacies to boost immunity which helps the prevention of various kind infectious diseases. Recently, the outbreak of corona virus has been noticed which mainly involve Respiratory system. Ayurveda, being the science of life, propagates the gifts of nature in maintaining healthy and happy living. Ayurveda's extensive knowledge base on preventive care, derives from the concepts of "Dinacharya" daily regimes and "Ritucharya" seasonal regimes to maintain healthy life. In Homoeopathy the choice of the medicine is fundamentally based on the principle that the medicine must have the capability of producing most similar symptom of the diseases to be cure in healthy persons. Today whole world faces corona virus problem. Corona virus comprises of a large family of viruses that are common in human beings as well animals camels, cattle, cats, and bats . The novel Corona virus disease COVID 19 has been spreading at a rapid rate across the world, which made World health organization WHO to declare it as a pandemic disease. A lot is still unknown about this virus. Signs and symptoms of corona virus disease 2019 COVID 19 may appear two to 14 days after exposure. The virus spreads by respiratory droplets released when someone with the virus coughs, sneezes or talks. It can also spread if a person touches a surface with the virus on it and then touches his or her mouth, nose or eyes. Today the only or basic prevention from this disease is "stay home", "wash your hands often with soap and water for at least 20 seconds" and "cover your face with a cloth face covering in public spaces." Some of the important preventive measure is uses by government of india is Aarogya Setu app and Lockdown condition in country. As we all know there is no vaccine or medicine available against corona virus. So, prevention and good immunity is necessary for everyone because it is spread human to human. In Rajasthan, a combination of anti malaria, anti Swine flu and anti HIV drugs resulted into recovery. For boosting immunity daily practice of Yogasana, Pranayama and meditation for at least 30 minutes and some diet plan are advised by Ministry of AYUSH YOGAatHome StayHome StaySafe . Some enthusiastic slogans, poems, songs, videos, images, drawings are circulating on internet to showing unity by people towards nation and against corona. Dr. Jyoti Gangwal | Dr. Sanjay Kholiya | Dr. Kavita Gangwal "Covid-19: Scope of Ayurveda and Homoeopathy to Make Swastha Bharat" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-4 , June 2020, URL: https://www.ijtsrd.com/papers/ijtsrd30895.pdf Paper Url :https://www.ijtsrd.com/medicine/ayurvedic/30895/covid19-scope-of-ayurveda-and-homoeopathy-to-make-swastha-bharat/dr-jyoti-gangwal
Small Arms Lethality variables 1.6e DRAFTJA Larson
small arms lethality is a complex equation.
military operations are generally a team event.....more like football or soccer than tennis......
therefore teamwork and safety adds complexity
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
1. Vitamin D deficiency in Ireland
– implications for COVID-19.
Results from The Irish
Longitudinal Study on Ageing
(TILDA)
2020
2.
3. Vitamin D deficiency in Ireland –
implications for COVID-19. Results
from the Irish Longitudinal Study on
Ageing (TILDA)
Eamon Laird & Rose Anne Kenny
The Irish Longitudinal Study on Ageing
On behalf of the TILDA team
April 2020
5. Acknowledgements
We would like to acknowledge the vision and commitment of our study funders, the
Department of Health, the Health Research Board, Science Foundation Ireland, The
Atlantic Philanthropies, and Irish Life plc. We would like to state that any views expressed
in this report are not necessarily those of the Department of Health or of the Minister for
Health. We would also like to thank the TILDA participants without whom this research
would not be possible.
6. Contents
1. Introduction..................................................................................................1
2. The TILDA Sample......................................................................................3
3. Vitamin D Status of Older Adults in Ireland in Winter..................................5
4. Vitamin D Status of Older Adults in Ireland in Summer............................. 11
5. Vitamin D Status by Obesity and Respiratory Lung Conditions................18
6. Discussion.................................................................................................21
7. References................................................................................................23
7. Appendix....................................................................................................25
7.
8. Key Messages
1. Why is Vitamin D important?
• Vitamin D is essential for bone and muscle health
• Vitamin D may help prevent respiratory infections in those who have low vitamin D
levels
• Vitamin D is seasonal and cannot be made during the winter-time while the amount in
summer time is subject to sunshine, weather and other factors
2. What are the rates of deficiency in older adults in Ireland*1
?
• 47% of all adults aged >85 are deficient in winter (31,480)
• 27% of the over 70s who are ‘cocooning’ are likely to be deficient (115,536)
• 1 in 8 (13%) adults over 55 are deficient (149,049) all year
3. Who is at risk of Vitamin D deficiency in Ireland?
• People who are housebound/confined, little sun exposure and/or eat inadequate
amounts of fortified foods
• People who don’t take vitamin D supplements - currently over 91% of older adults 55+
do not take a supplement during the winter (1,038,752). Only 4% of men and 15% of
women take a supplement
• People who are obese, physically inactive, have asthma or chronic lung disease
4. Where is vitamin D found
• Vitamin D is made in the skin from 10-15 minutes per day of sun exposure - in Ireland
only made from late March to late September
• Vitamin D is available in oily fish (salmon, mackerel etc.), eggs, liver, fortified foods
such as cereals and dairy products
5. How much vitamin D should be taken to prevent deficiency?
• 10 ug (400 IU) is the minimum recommended daily during the winter time
• Between 15 -20 ug (800-1,000 IU/day) recommended for most at risk groups
1 For further information see: Laird E, O’Halloran AM, Carey D, Healy M, O’Connor D, Moore P,
Shannon T, Molloy AM, Kenny RA. The prevalence of vitamin D deficiency and the determinants of 25
(OH)D concentration in older Irish adults: Data from The Irish Longitudinal Study on Ageing (TILDA). The
Journals of Gerontology: Series A. 2018 73(4):519-525. https://academic.oup.com/biomedgerontology/
article/73/4/519/4103040
9. 1
In this report, we aim to describe the importance of vitamin D for immune function, the
prevalence of vitamin D deficiency and vitamin D supplement use in Ireland by age group,
gender, geographic location and by obesity and lung disease (particularly vulnerable to
COVID-19), describe those most at risk of deficiency and the best sources of vitamin D
and recommendations to improve status. By compiling this report, we hope the information
given can help in the mitigation of the negative health consequences of COVID-19.
Frailty is a dynamic process that changes over time and can be viewed on a continuum.
An older person can transition in either direction between the different states of frailty,
namely robustness, pre-frailty (an intermediate state) and frailty (9). Robust older people
may have some health problems, but in general these problems are being well managed.
Older people with pre-frailty are at an increased risk of adverse outcomes but are coping.
Individuals living with frailty generally require some support for instrumental and/or basic
activities of daily living, have increased susceptibility to infection, take longer to recover
from infections and are less likely to recover to previous levels of functional independence.
For older adults living with frailty, exposure to a stressor such as infection significantly
increases the risk of disability, hospital admission, longer in-patient length of stay, transition
to long-term care and death (10). It is highly likely that individuals living with frailty who
contract COVID-19 are at greatest risk for admission to hospital, admission to critical and
intensive care units and death. Identifying people living with frailty provides an opportunity
to prevent this at-risk group from contracting COVID-19 in the community and proactively
to develop healthcare service planning and delivery for our medically vulnerable population
aged 70+ years (11).
1.1 Vitamin D and immune function
Vitamin D is essential for older adults to help maintain bone and muscle health, plays a
key role in the prevention and the treatment of falls and fractures and helps the absorption
of calcium from the gut (2). Recent research has also highlighted that it may have an
important function within the immune system (3). With increased age, there is a shift in the
immune response to a more pro-inflammatory state which may lead to chronic low level
inflammation and a slow accumulation of damage, with subsequent progression to chronic
disease. This age related pro-inflammatory state is referred to as ‘inflamm-aging’ (4). This
can be particularly important in periods of metabolic stress such as infection - the body
1. Introduction
10. 2
1 Introduction
is already pre-set to a higher level of inflammation and the necessary immune response
to the infection may be impaired. Experiments and research has shown that vitamin
D can alter the immune system response through its influence on the production and
manufacturing of immune molecules known as cytokines (5). Vitamin D has been shown
to help signal the increased production of ant-inflammatory molecules and decrease the
production of pro-inflammatory molecules (6,7). This switch in immune response in theory
may have some potential benefit in cases of ‘cytokine storm’ – a massive release of pro-
inflammation (which has been observed in those infected with COVID (8)) which can cause
acute respiratory distress syndrome (9). Importantly, in a large cross-sectional clinical trial
(n = 18,883) the risk of respiratory infection increased with lower blood vitamin D levels and
the effect was even stronger in those with underlying lung conditions (10). Many case-
control studies have also reported associations between low vitamin D and increased risk
of infection (11) while in a trial supplementing patients at risk of respiratory infection with
1,000 International units (IU) of vitamin D a day for a year, supplement use reduced both
symptoms and antibiotic use (12).
Recently, a large meta-analysis (data analysis of a large collection of previous studies)
of 10,933 people from 25 trials conducted in 15 countries investigated whether taking a
vitamin D supplement helped to prevent colds, flu and chest infections (acute respiratory
infections - ARIs) (13). Vitamin D had a significant protective effect when it was given
daily or weekly to people with lowest vitamin D levels: the risk of having at least one ARI
was reduced from 60% to 32% in these people. Overall, vitamin D supplements reduced
the risk of having at least one ARI. The study authors concluded that taking a vitamin D
supplement was safe and can help protect against ARIs, particularly if baseline levels are
low. In 2019, a newer analysis using 21,000 participants from across eight studies showed
that those with a low blood vitamin D level had a 64% increased risk of community-
acquired pneumonia (14).
Therefore, maintaining a sufficient vitamin D status in the adults is beneficial in prevention
of ARI and may therefore be of benefit in the COVID-19 pandemic.
11. 3
This report uses data collected in Wave 1 of The Irish Longitudinal Study on Ageing
(TILDA), a prospective study of 8,172 community-dwelling adults aged 50 years and
older in Ireland. Since 2009, TILDA has collected information about the health and social
circumstances of older adults using a comprehensive Computer Assisted Personal
Interview (CAPI) conducted by interviewers who visited the participants in their own
homes. This included detailed questions on socio-demographics, physical, mental and
behavioural health. Information recorded included gender, age, habitation (living alone yes/
no), currently smoking (yes/no), lung condition (yes/no), province of residence: (Leinster
- East, Munster - South and the combined provinces of Ulster/Connacht - West/North)
and household housing wealth (measure of economic resource “asset wealth” defined
as above or below the average of 278,359 Euros). Medications taken on a daily basis
including prescription, non-prescription and vitamin D supplements were also recorded.
Self-reported physical activity levels were classified using the International Physical
Activity Questionnaire (IPAQ) categories: physically active (minimally or health enhancing
physically active) versus physically inactive (inactive or insufficiently active). Obesity was
measured as a body mass index (BMI) > 30 kg/m2.
Approximately 72.1% (n = 5,895) of the study population consented to, and participated
in, a health assessment. Of those, 91.3% (n = 5,382) provided a blood sample for vitamin
D (25-hydroxyvitamin D (25(OH)D) measurement. In this report we use the internationally
accepted definitions of vitamin D status: deficient (< 30 nmol/L); insufficient (30 -50 nmol/L)
and sufficient (>50 nmol/L). Given that vitamin D is a seasonal vitamin, this had to be
accounted for in any analysis of population prevalence. Thus, seasons were defined as
winter (December-February), spring (March-May), summer (June-August), and autumn
(September-November). Low and high vitamin D periods were defined as winter (with
spring) and summer (with autumn), respectively.
2.1 Statistical Methods and Weighting
In this report, all TILDA prevalence estimates are weighted to account for age, sex,
educational attainment and urban/rural residence in the 2011 Census (Wave 1 of TILDA
collection). Prevalence estimates were also adjusted using modified base weights that
accounted for survey non-response, non-attendance at the health assessment component
of the study and whether or not respondents provided a blood sample. These weights
2. The TILDA Sample
12. 4
2 The TILDA Sample
and adjustments ensure that these estimates are representative of the whole population
aged 50 years and over in Ireland. All of the calculated population estimates are then
based on figures collected from the most recent 2016 Census data (which reported a total
of 1,446,460 people over 50 living in Ireland. It should be noted that the TILDA sampling
frame does not include people with dementia at baseline or people living in nursing homes
and as such this data may slightly underestimate prevalence for the total population in
Ireland.
In light of the new HSE ‘Guidance on cocooning to protect people over 70 years and those
extremely medically vulnerable from COVID-19’ (1) which came into effect from midnight
on March 28th 2020, this report will also provide information in relation to vitamin D status
in adults aged 70 years and over.
In light of the new HSE ‘Guidance on coccooning to protect people over 70 years
and those extremely medically vulnerable from COVID-19’ which came into effect
from midnight on March 28th 2020, this report will also provide information in
relation to frailty on adults aged 70 and over.
13. 5
During the winter period, 21.3% (244,209) of adults aged >55 years were vitamin D
deficient (Figure 1; Table 2). The highest rates of deficiency were observed for those aged
80-84 years (29.6%; 23,987) and those aged >85 years (46.6%; 31,480). For those aged
>70 years, the deficiency rates were 27.1% (115,536). Across all ages, deficiency rates
were similar for both men and women though with men tending to have slightly higher
deficiency rates overall.
Similar high rates of deficiency were observed when examined by province of residence
(Figure 2; Table 3). Again, those aged >85 years had the highest rates of deficiency
regardless of province. However, those aged 85+ in the Connacht & Ulster area had the
highest deficiency rate (59.5%; 8,738). For those aged >70 years, the Munster region
had the highest deficiency rate (31.8%; 39,410) vs the Leinster region (21.4%; 46,231).
Overall, Leinster had the lowest rate of deficiency (17.6%; 103,615) compared to those
residing in either Munster (25.3%; 83,615) or Connacht & Ulster (24.5%; 55,690).
In winter, only 9.4% (107,773) of those aged 55+ and 11.5% (49,028) of those aged 70+
reported taking a vitamin D supplement (Table 4). A much higher proportion of women
(14.6%; 87,181) compared to men (3.8%; 20,877) took a supplement. This sex difference
was consistent when examined by age as for instance, in those aged 85+ only 5.6%
(1,291) of men vs 17.7% (7,875) of women reported taking a supplement..
3. Vitamin D Status of Older Adults in Ireland
in Winter
14. 6
3 Vitamin D Status of Older Adults in Ireland in Winter
Figure1.WintervitaminDdeficiencyratesinolderadultsinIrelandbyageandgender
15. 7
Vitamin D deficiency in Ireland – implications for COVID-19. Results from the Irish Longitudinal Study on Ageing (TILDA)
Table2.PercentprevalenceofvitaminDstatus(winter)inTILDA(Wave1)extrapolatedtoCSOpopulationestimatedatafrom2016
WintertimeTILDA(%,Wave1)CSO(n,2016)
AgegroupDeficientInsufficientSufficientDeficientInsufficientSufficientTotal
Total
55+years21.333.245.5244,209380,647521,6691,146,525
70+years27.129.743.2115,536126,620184,175426,331
55-59years18.438.343.349,698103,449116,955270,102
60-64years17.63349.442,03978,823117,994238,856
65-69years18.434.247.438,86772,243100,126211,236
70-74years23.532.144.438,13452,08972,049162,272
75-79years21.130.748.224,36335,44955,655115,467
80-84years29.634.535.923,98727,95829,09281,037
85+years46.614.43931,4809,72826,34767,555
Male
55+years22.736.940.4124,712202,726221,955549,393
70+years26.835.038.251,30266,99973,125191,426
55-59years18.94140.125,29954,88253,677133,858
60-64years22.337.340.426,47044,27447,954118,698
65-69years21.634.144.322,67235,79246,498104,961
70-74years21.838.24017,23330,19731,62079,051
75-79years21.531.447.111,63516,99325,48954,117
80-84years37.234.82813,09312,2489,85535,196
85+years48.440.910.711,1629,4322,46823,062
Female
55+years20.229.850120,621177,945298,566597,132
70+years27.725.347.064,94459,327110,194234,455
55-59years18.94140.125,75055,86054,634136,244
60-64years13.428.757.916,10134,48569,571120,158
65-69years1534.250.815,94136,34653,988106,275
70-74years25.825.348.921,35520,94140,47582,771
75-79years2129.849.212,88418,28230,18461,350
80-84years26.633.739.712,19415,44818,19945,841
85+years445.250.819,5772,31422,60244,493
16. 8
3 Vitamin D Status of Older Adults in Ireland in Winter
Figure2.WintervitaminDdeficiencyratesbyageandprovinceinolderadultsinIreland
17. 9
Vitamin D deficiency in Ireland – implications for COVID-19. Results from the Irish Longitudinal Study on Ageing (TILDA)
Table3.PercentprevalenceofvitaminDstatus(winter)inTILDA(Wave1)extrapolatedtoCSOpopulationestimatedatafrom2016
WintertimeTILDA(%,Wave1)CSO(n,2016)
AgegroupDeficientInsufficientSufficientDeficientInsufficientSufficientTotal
Leinster
55+years17.633.748.7103,615198,400286,709588,724
70+years21.42751.646,23158,329111,474216,035
55-59years15.840.843.422,50058,10261,805142,408
60-64years15.733.950.419,32541,72762,037123,089
65-69years15.83747.216,93639,66150,595107,192
70-74years19.627.752.716,15522,83143,43782,424
75-79years13.731.255.18,08218,40532,50358,990
80-84years1732.250.86,93513,13520,72340,793
85+years45.812.24215,4934,12714,20833,828
Munster
55+years25.333.241.583,615109,724137,155330,493
70+years31.833.534.739,41041,51743,004123,930
55-59years20.734.145.215,77425,98634,44576,205
60-64years22.331.146.615,29122,69631,95368,569
65-69years20.834.944.312,85221,56427,37361,789
70-74years21.540.737.810,22919,36317,98347,575
75-79years35.225.439.411,8268,53413,23833,598
80-84years38.540.121.49,1319,5105,07523,716
85+years40.828.530.77,7695,4275,84619,041
Connacht&Ulster
55+years24.532.642.955,69074,10297,515227,308
70+years3330.736.328,50126,51431,35186,366
55-59years21.237.940.910,91619,51421,05951,489
60-64years14.534.750.86,84416,37823,97747,198
65-69years21.925.452.79,25410,73322,26842,255
70-74years35.829.334.911,5549,45611,26332,273
75-79years17.138.244.73,9128,74010,22722,879
80-84years36.336.7276,0006,0664,46316,528
85+years59.5040.58,73805,94814,686
18. 10
3 Vitamin D Status of Older Adults in Ireland in Winter
Table 4. Prevalence of vitamin D supplement use (winter) in TILDA (Wave 1) by province
extrapolated to CSO population estimate data from 2016
Winter time TILDA (%, Wave 1) CSO (n, 2016)
Age group Yes No Yes No Total
Total
55+ years 9.4 90.6 107,773 1,038,752 1,146,525
70+ years 11.5 88.5 49,028 377,303 426,331
55-59 years 5.6 94.4 15,126 254,976 270,102
60-64 years 9.6 90.4 22,930 215,926 238,856
65-69 years 9.6 90.4 20,279 190,957 211,236
70-74 years 11.5 88.5 18,661 143,611 162,272
75-79 years 13.9 86.1 16,050 99,417 115,467
80-84 years 7.6 92.4 6,159 74,878 81,037
85+ years 13.5 86.5 9,120 58,435 67,555
Male
55+ years 3.8 96.2 20,877 528,516 549,393
70+ years 4.8 95.2 9,188 182,238 191,426
55-59 years 2.2 97.8 2,945 130,913 133,858
60-64 years 4.1 95.9 4,867 113,831 118,698
65-69 years 3.6 96.4 3,779 101,182 104,961
70-74 years 5.4 94.6 4,269 74,782 79,051
75-79 years 5 95 2,706 51,411 54,117
80-84 years 4.6 95.4 1,619 33,577 35,196
85+ years 5.6 94.4 1,291 21,771 23,062
Female
55+ years 14.6 85.4 87,181 509,951 597,132
70+ years 16.7 83.3 39,151 195,284 234,435
55-59 years 9.3 90.7 12,671 123,573 136,244
60-64 years 15.1 84.9 18,144 102,014 120,158
65-69 years 15.3 84.7 16,260 90,015 106,275
70-74 years 17.8 82.2 14,733 68,038 82,771
75-79 years 21.8 78.2 13,374 47,976 61,350
80-84 years 9.2 90.8 4,217 41,624 45,841
85+ years 17.7 82.3 7,875 36,618 44,493
19. 11
During the summer period (optimum period for making vitamin D from sunlight), 8.4%
(96,308) of adults aged >55 years were vitamin D deficient (Figure 3; Table 5) while for
those aged 70+, the rate of deficiency was 12.1% (51,586). The highest rates of deficiency
were observed for those aged 85+ years (30.7%; 20,739). Similar age defined rates were
observed for both men and women though with women having slightly higher deficiency
rates overall.
Similar rates of deficiency were observed when examined by province of residence (Figure
4; Table 6). Again, those aged >85 years had the highest rates of deficiency regardless
of province. However, those aged 85+ in the Connacht & Ulster area had the highest
deficiency rate (48.3%; 7,093) followed by Munster area (41.1%; 7,826) and then Leinster
(20.7%; 7,002). Overall, Leinster again had the lowest rate of deficiency (6.8%; 40,033)
compared to those residing in either Munster (9.5%; 31,397) or Connacht & Ulster (10.0%;
22,731). For those aged 70+, those residing in Munster had a deficiency rate of 15.9%
(19,705) vs 10.3% (22,252) in Leinster.
In summer, 10.3% (118,092) of those aged 55+ reported taking a vitamin D supplement
(Table 7). Again, a much higher proportion of women (14.6%; 87,181) compared to men
(5.5%; 30,217) took a supplement. For those aged 70+, only 14.2% (60,539) took a vitamin
D supplement.
4.1 Risk factors for deficiency
The risk factors for vitamin D deficiency are displayed in Figure 5. The largest negative
predictors included smoking, geographic location (living in the North and West compared
to the East of the country), winter season, physically inactivity, and older age. The largest
positive predictor of vitamin D was vitamin D supplement use followed by being female.
4. Vitamin D Status of Older Adults in Ireland
in Summer
20. 12
4 Vitamin D Status of Older Adults in Ireland in Summer
Figure3.SummervitaminDdeficiencyratesinolderadultsinIrelandbyageandgender
21. 13
Vitamin D deficiency in Ireland – implications for COVID-19. Results from the Irish Longitudinal Study on Ageing (TILDA)
Table5.PercentprevalenceofvitaminDstatus(summer)inTILDA(Wave1)extrapolatedtoCSOpopulationestimatedatafrom2016
SummertimeTILDA(%,Wave1)CSO(n,2016)
AgegroupDeficientInsufficientSufficientDeficientInsufficientSufficientTotal
Total
55+years8.42764.696,308309,562740,6551,146,525
70+years12.131.95651,586136,000238,745426,331
55-59years5.32470.714,31564,824190,962270,102
60-64years7.423.868.817,67556,848164,333238,856
65-69years6.726.966.414,15356,822140,261211,236
70-74years7.528.364.212,17045,923104,179162,272
75-79years829.762.39,23734,29471,936115,467
80-84years12.536.451.110,13029,49741,41081,037
85+years30.741.827.520,73928,23818,57867,555
Male
55+years6.426.467.235,161145,040369,192549,393
70+years9.633.656.818,37764,319108,730191,426
55-59years519.775.36,69326,370100,795133,858
60-64years425.770.34,74830,50583,445118,698
65-69years5.924.269.96,19325,40173,368104,961
70-74years5.238.256.64,11130,19744,74379,051
75-79years2.634.862.61,40718,83333,87754,117
80-84years20.635.643.87,25012,53015,41635,196
85+years12.456.6312,86013,0537,14923,062
Female
55+years1027.462.659,713163,614373,805597,132
70+years13.930.655.532,58971,743130,123234,455
55-59years519.775.36,81226,840102,592136,244
60-64years10.821.667.612,97725,95481,227120,158
65-69years7.229.163.77,65230,92667,697106,275
70-74years9.729.860.58,02924,66650,07682,771
75-79years12.325.362.47,54615,52238,28261,350
80-84years6.537.5562,98017,19025,67145,841
85+years42.333.124.618,82114,72710,94544,493
22. 14
4 Vitamin D Status of Older Adults in Ireland in Summer
Figure4.SummervitaminDdeficiencyratesbyageandprovinceinolderadultsinIreland
23. 15
Vitamin D deficiency in Ireland – implications for COVID-19. Results from the Irish Longitudinal Study on Ageing (TILDA)
Table6.PercentprevalenceofvitaminDstatus(summer)inTILDA(Wave1)byprovinceextrapolatedtoCSOpopulationestimatedata
from2016
SummertimeTILDA(%,Wave1)CSO(n,2016)
AgegroupDeficientInsufficientSufficientDeficientInsufficientSufficientTotal
Leinster
55+years6.822.470.840,033131,874416,817588,724
70+years10.327.162.622,25258,545135,238216,035
55-59years3.619.277.25,12727,342109,939142,408
60-64years6.417.576.17,87821,54193,671123,089
65-69years4.325.670.14,60927,44175,142107,192
70-74years9.626.164.37,91321,51352,99982,424
75-79years5.22074.83,06711,79844,12558,990
80-84years11.32860.74,61011,42224,76140,793
85+years20.746.432.97,00215,69611,12933,828
Munster
55+years9.530.56031,397100,800198,296330,493
70+years15.935.648.519,70544,11960,106123,930
55-59years5.325.868.94,03919,66152,50576,205
60-64years6.132.161.84,18322,01142,37668,569
65-69years926.764.35,56116,49839,73061,789
70-74years8.72863.34,13913,32130,11547,575
75-79years15.436.448.25,17412,23016,19433,598
80-84years1544.440.63,55710,5309,62923,716
85+years41.134.9247,8266,6454,57019,041
Connacht&Ulster
55+years1034.355.722,73177,967126,611227,308
70+years10.339.150.68,89633,76943,70186,366
55-59years10.330.359.45,30315,60130,58451,489
60-64years11.432.755.95,38115,43426,38447,198
65-69years8.531.759.83,59213,39525,26842,255
70-74years034.265.8011,03721,23632,273
75-79years3.940.755.48929,31212,67522,879
80-84years11.842.146.11,9506,9587,61916,528
85+years48.334.417.37,0935,0522,54114,686
24. 16
4 Vitamin D Status of Older Adults in Ireland in Summer
Table 7. Prevalence of vitamin D supplement use (summer) in TILDA (Wave 1) by province
extrapolated to CSO population estimate data from 2016
Summer time TILDA (%, Wave 1) CSO (n, 2016)
Age group Yes No Yes No Total
Total
55+ years 10.3 89.7 118,092 1,028,433 1,146,525
70+ years 14.2 85.8 60,539 365,792 426,331
55-59 years 7.3 92.7 19,717 250,385 270,102
60-64 years 8.6 91.4 20,542 218,314 238,856
65-69 years 9 91 19,011 192,225 211,236
70-74 years 14 86 2,272 139,554 162,272
75-79 years 10.2 89.8 11,778 103,689 115,467
80-84 years 21.2 78.8 17,180 63,857 81,037
85+ years 10.1 89.9 6,823 60,732 67,555
Male
55+ years 5.5 5.5 30,217 519,176 549,393
70+ years 9.1 90.9 17,420 174,006 191,426
55-59 years 3.9 3.9 5,220 128,638 133,858
60-64 years 3.7 3.7 4,392 114,306 118,698
65-69 years 3.7 3.7 3,884 101,077 104,961
70-74 years 8.9 8.9 7,036 72,015 79,051
75-79 years 4.8 4.8 25,976 51,519 54,117
80-84 years 11.5 11.5 4,048 31,148 35,196
85+ years 16.7 16.7 3,851 19,211 23,062
Female
55+ years 14.6 85.4 87,181 509,951 597,132
70+ years 18.1 81.9 42,436 192,019 234,455
55-59 years 10 90 13,624 122,620 136,244
60-64 years 13.4 86.6 16,101 104,057 120,158
65-69 years 14.2 85.8 15,091 91,184 106,275
70-74 years 18.2 81.8 15,064 67,707 82,771
75-79 years 14.7 85.3 9,018 52,332 61,350
80-84 years 28.2 71.8 12,927 32,914 45,841
85+ years 6.4 93.6 2,848 41,645 44,493
25. 17
Vitamin D deficiency in Ireland – implications for COVID-19. Results from the Irish Longitudinal Study on Ageing (TILDA)
Figure 5. Factors which can influence blood vitamin D levels in older Irish adults
26. 18
Overall, obese older adults had much higher rates of vitamin D deficiency both in winter
and summer (Figures 6-7). During winter, rates of vitamin D deficiency in the obese were
27.3% for those aged 55+ and 35.3% for those aged 70+ compared to 20.8% and 27.0%
respectively for those not obese. Similar trends were also observed during summer.
In those reporting chronic lung disease (such as chronic bronchitis or emphysema),
the prevalence of vitamin D deficiency was significantly higher than those not reporting
disease across the age groups both in winter and summer (Figures 8-9). For instance in
those aged >55 years, the prevalence in winter of deficiency was 33.8% in those with lung
conditions vs 22.7% with no conditions. Similar trends were observed in 70+ age group
where rates were 32 vs 29.9% in winter and 16.9 vs 12.3% in summer
5.Vitamin D status by obesity and respiratory
lung conditions
27. 19
Vitamin D deficiency in Ireland – implications for COVID-19. Results from the Irish Longitudinal Study on Ageing (TILDA)
Figure6.VitaminDdeficiencyinolderadultsinIrelandwithobesitybyage(winter)
Figure7.VitaminDdeficiencyinolderadultsinIrelandwithobesitybyage(summer)
28. 20
4 Vitamin D Status of Older Adults in Ireland in Summer
Figure7.VitaminDdeficiencyinolderadultsinIrelandwithlungconditions(winter)byage
Figure7.VitaminDdeficiencyinolderadultsinIrelandwithlungconditions(summer)byage
29. 21
This report demonstrates that of those aged 55+ years in Rep. of Ireland, 1 in 5 are
vitamin D deficient during the winter and 1 in 12 during the summer. Of particular concern
is that nearly 30% of those aged 70+ and 47% of those aged 85+ are deficient in vitamin
D. These are the age groups who are considered to be ‘extremely medically vulnerable’
to the adverse health outcomes of COVID-19 and have been advised to participate in
‘cocooning’ during the COVID-19 public health emergency. Of extra concern is the fact that
only 10.5% of those aged 70+ actually report taking a vitamin D supplement – because of
‘cocooning’ many may now lack the opportunity for sun exposure and given the low use of
supplements, many of this vulnerable group could be at very high risk of deficiency. This
of key importance given the usefulness of vitamin D for immune function particularly at this
time.
Of particular concern we have observed very high levels of vitamin D deficiency in those
who are obese and those with pre-existing lung conditions both of which have been
observed to make individuals particularly vulnerable to COVID-19 and complications from
the virus (15,16).
Ireland does not have any formal vitamin D food policy – we practice a voluntary but
not mandatory food fortification policy where food manufacturers can decide to fortify
(or not) their food products with vitamin D. The vitamin D status of those in Ireland is
lower than either the United States or Canada who have systematic (mass) vitamin D
food fortification. However, vitamin D deficiency is not inevitable in older adults in Ireland
and the ability to have sufficient vitamin D status year round is an achievable goal that
many countries meet. For example, another European country - Finland (which is at a
much higher latitude and therefore receives less sunshine than Ireland) has virtually
eliminated vitamin D deficiency in its population with rates <1% (17). This is due in part to
a successful food fortification and vitamin D supplement policy and educating the public
and medical practitioners on the importance of vitamin D. This vitamin D success story
demonstrates what could be achieved in Ireland.
6. Discussion
30. 22
4 Vitamin D Status of Older Adults in Ireland in Summer
Here we outline the main sources of vitamin D and what are the intake
recommendations
Vitamin D sources
There are three main sources of vitamin D – sunlight, food and supplements. Due to
Ireland’s far latitude geographic location, vitamin D synthesis by sunlight is only during the
months of late March to late September. This is 10-15 minutes exposure to sunlight (before
application with sun-protection at a time period between 12-4 pm). However, even during
the summer, the amount of vitamin D that can be made is affected by cloud cover, use of
skin creams, clothing, obesity and age (18). Foods rich in this micronutrient include oily
fish (tinned or fresh salmon, mackerel etc.), egg yolks, liver and vitamin D fortified foods
such as cereals and dairy products (Appendix 1). Regular consumption of vitamin D rich
foods is recommended to help prevent deficiency, particularly in the winter months and
those not exposed to sunshine in the summer time.
Vitamin D Intake recommendations
During the winter-period at least 10 ug/day (400 IU) from the diet is required (due to
the lack of sunlight for vitamin D synthesis). Recent data has shown that the average
intakes from diet are significantly below this level and therefore a 10 ug (400 IU) vitamin D
supplement maybe be required during the winter. For those who are housebound (due to
illness or quarantine for an extended period) an upper supplement of 15-20 ug/day (600-
800 IU) maybe required due to the lack of sunshine exposure. In persons over 70 years,
20-25 ug/day (800-100IU) is recommended.
6.1 Conclusion
Our people aged 70 and over are the fabric of our society (19) and we must use all
available tools to facilitate the reduction and transmission of COVD-19. Vitamin D is a
potent immune modifying micronutrient and if vitamin D status is sufficient, it could benefit
vulnerable adults in particular those 70+ years and older who are ‘cocooning’ during the
COVID-19 outbreak.
31. 23
7. References
1. Guidance on cocooning to protect people over 70 years and those extremely medically
vulnerable from COVID-19. Health Service Executive (HSE), Republic of Ireland.
27 March 2020. https://www.hpsc.ie/az/respiratory/coronavirus/novelcoronavirus/
guidance/vulnerablegroupsguidance/COVID-19%20Guidance%20for%20
extremely%20medically%20vulnerable%20V1.pdf
2. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Institute of
Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The
National Academies Press; 2011.
3. Vanherwegen AS, Gysemans C, Mathieu. Regulation of immune function by vitamin D
and its use in diseases of immunity. Endocrinol Metab Clin. 2017;46:1061-1094.
4. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular
disease, and frailty. Nat Rev Cardiol. 2018; 15(9):505-522.
5. Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful
immuno-modulator. Immunology. 2011;134:123-139.
6. Laird E, McNulty H, Ward M, Hoey L, McSorley E, Wallace JM, et al. Vitamin D
deficiency is associated with inflammation in older Irish adults. J Clin Endocrinol Metab.
2014;99(5):1807-1815.
7. Sloka S, Silva C, Wang J, Yong VW. Predominance of Th2 polarization by vitamin D
through a STAT6-dependent mechanism. J Neuroinflammation. 2011;8(1):56.
8. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506
9. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of
COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory
medicine. 2020 Feb 18.
32. 24
4 Vitamin D Status of Older Adults in Ireland in Summer
10. Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin
D level and upper respiratory tract infection in the Third National Health and Nutrition
Examination Survey. Arch Intern Med. 2009;169:384–390.
11. Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory
infection: Systematic review of clinical studies. J Steroid Biochem Mol Biol.
2013;136:321-329.
12. Bergman P, Norlin AC, Hansen S, Rekha RS, Agerberth B, Björkhem-Bergman L, et
al. Vitamin D3 supplementation in patients with frequent respiratory tract infections: a
randomised and double-blind intervention study. BMJ Open. 2012;2(6):e001663.
13. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin
D supplementation to prevent acute respiratory tract infections: systematic review and
meta-analysis of individual participant data. BMJ. 2017;356:i6583.
14. Zhou YF, Luo BA, Qin LL. The association between vitamin D deficiency and
community-acquired pneumonia: A meta-analysis of observational studies. Medicine
(Baltimore). 2019;98:e17252.
15. Jia X, Yin C, Lu S, Chen Y, Liu Q, Bai J, Lu Y. Two Things about COVID-19 Might Need
Attention. Preprints. 2020, 2020020315 (doi: 10.20944/preprints202002.0315.v1)
16. Thornton J. Don’t forget chronic lung and immune conditions during covid-19, says
WHO. BMJ. 2020;368:m1192
17. Jääskeläinen T, Itkonen ST, Lundqvist A, Erkkola M, Koskela T, Lakkala K, et l. The
positive impact of general vitamin D food fortification policy on vitamin D status in a
representative adult Finnish population: evidence from an 11-y follow-up based on
standardized 25-hydroxyvitamin D data. AJCN. 2017;105(6):1512-20
18. Laird E, Ward M, McSorley E, Strain JJ, Wallace J. Vitamin D and bone health;
Potential mechanisms. Nutrients. 2010;2(7):693-724.
19. McGarrigle CA, Ward M, Scarlett S, Kenny RA. (2020) THE CONTRIBUTIONS OF
THE OVER 70S TO IRISH SOCIETY: RESULTS FROM WAVE 5 OF THE IRISH
LONGITUDINAL STUDY ON AGEING. https://www.doi.org/10.38018/TildaRe.2020-01
33. 25
Appendix Table 1. Common dietary sources of vitamin D
Dietary source Quantity Vitamin D (µg)* Vitamin D (IU)
Egg 1 egg 1.6 64
Liver (lamb) 100g 0.9 36
Kidney (Lamb) 100g 0.6 24
Salmon 140g 10.2 408
Mackerel 140g 11.9 476
Sardines (canned in oil) 100g 5 200
Fortified milks 200ml (glass) 4 160
Fortified cereals 35g 2.94 117.6
*10ug or 400 IU per day suggested requirements
Appendix Table 2. Factors that can influence vitamin D status
Reason Notes
1 Geographic location Far latitude countries most at risk
2 Season (Winter vs Summer) Majority of vitamin D is made in Summer
3 Low sun exposure Due to sun-cream, clothing or skin pigmentation
4 Age Older age, infants and pregnant women at risk
5 Obesity BMI >25 kg/m2 at risk
6 Smoking Sustainably increased risk of deficiency
7 Poverty Can result in low sun exposure (holidays) or poor diet
8 Poor diet Low intakes of oily fish, eggs, fortified foods
9 Malabsorption syndromes This can include Coeliac, Crohn’s etc.
10 Genetic conditions Can result in lower blood vitamin D
7. Appendix